10-[3-phenoxazin-10-yl-5-(1-phenylbenzimidazol-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(3-phenylimidazo[4,5-b]pyridin-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(1-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(3-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]phenoxazine

C169H109N19O8 — CID 157273505

IUPAC10-[3-phenoxazin-10-yl-5-(1-phenylbenzimidazol-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(3-phenylimidazo[4,5-b]pyridin-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(1-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(3-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]phenoxazine
SMILESc1ccc(-n2c(-c3cc(N4c5ccccc5Oc5ccccc54)cc(N4c5ccccc5Oc5ccccc54)c3)nc3ccccc32)cc1.c1ccc(-n2c(-c3cc(N4c5ccccc5Oc5ccccc54)cc(N4c5ccccc5Oc5ccccc54)c3)nc3cccnc32)cc1.c1ccc(-n2c(-c3cc(N4c5ccccc5Oc5ccccc54)cc(N4c5ccccc5Oc5ccccc54)c3)nc3ccncc32)cc1.c1ccc(-n2c(-c3cc(N4c5ccccc5Oc5ccccc54)cc(N4c5ccccc5Oc5ccccc54)c3)nc3cnccc32)cc1
InChIInChI=1S/C43H28N4O2.3C42H27N5O2/c1-2-14-30(15-3-1)47-34-17-5-4-16-33(34)44-43(47)29-26-31(45-35-18-6-10-22-39(35)48-40-23-11-7-19-36(40)45)28-32(27-29)46-37-20-8-12-24-41(37)49-42-25-13-9-21-38(42)46;1-2-13-29(14-3-1)47-41(44-32-15-12-24-43-42(32)47)28-25-30(45-33-16-4-8-20-37(33)48-38-21-9-5-17-34(38)45)27-31(26-28)46-35-18-6-10-22-39(35)49-40-23-11-7-19-36(40)46;1-2-12-29(13-3-1)47-33-22-23-43-27-32(33)44-42(47)28-24-30(45-34-14-4-8-18-38(34)48-39-19-9-5-15-35(39)45)26-31(25-28)46-36-16-6-10-20-40(36)49-41-21-11-7-17-37(41)46;1-2-12-29(13-3-1)47-37-27-43-23-22-32(37)44-42(47)28-24-30(45-33-14-4-8-18-38(33)48-39-19-9-5-15-34(39)45)26-31(25-28)46-35-16-6-10-20-40(35)49-41-21-11-7-17-36(41)46/h1-28H;3*1-27H
InChIKeyAYUWLKUULXCTDE-UHFFFAOYSA-N
MW2533.86 g/mol
LogP45.56
Rot. Bonds16

About 10-[3-phenoxazin-10-yl-5-(1-phenylbenzimidazol-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(3-phenylimidazo[4,5-b]pyridin-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(1-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(3-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]phenoxazine

10-[3-phenoxazin-10-yl-5-(1-phenylbenzimidazol-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(3-phenylimidazo[4,5-b]pyridin-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(1-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(3-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]phenoxazine (PubChem CID 157273505) has the molecular formula C169H109N19O8 and a molecular weight of 2533.86 g/mol. Its IUPAC name is 10-[3-phenoxazin-10-yl-5-(1-phenylbenzimidazol-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(3-phenylimidazo[4,5-b]pyridin-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(1-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(3-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]phenoxazine.

Molecular Properties

Compound Name10-[3-phenoxazin-10-yl-5-(1-phenylbenzimidazol-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(3-phenylimidazo[4,5-b]pyridin-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(1-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(3-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]phenoxazine
PubChem CID157273505
Molecular FormulaC169H109N19O8
Molecular Weight2533.86 g/mol
Exact Mass2531.87
IUPAC Name10-[3-phenoxazin-10-yl-5-(1-phenylbenzimidazol-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(3-phenylimidazo[4,5-b]pyridin-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(1-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(3-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]phenoxazine
SMILESc1ccc(-n2c(-c3cc(N4c5ccccc5Oc5ccccc54)cc(N4c5ccccc5Oc5ccccc54)c3)nc3ccccc32)cc1.c1ccc(-n2c(-c3cc(N4c5ccccc5Oc5ccccc54)cc(N4c5ccccc5Oc5ccccc54)c3)nc3cccnc32)cc1.c1ccc(-n2c(-c3cc(N4c5ccccc5Oc5ccccc54)cc(N4c5ccccc5Oc5ccccc54)c3)nc3ccncc32)cc1.c1ccc(-n2c(-c3cc(N4c5ccccc5Oc5ccccc54)cc(N4c5ccccc5Oc5ccccc54)c3)nc3cnccc32)cc1
InChIInChI=1S/C43H28N4O2.3C42H27N5O2/c1-2-14-30(15-3-1)47-34-17-5-4-16-33(34)44-43(47)29-26-31(45-35-18-6-10-22-39(35)48-40-23-11-7-19-36(40)45)28-32(27-29)46-37-20-8-12-24-41(37)49-42-25-13-9-21-38(42)46;1-2-13-29(14-3-1)47-41(44-32-15-12-24-43-42(32)47)28-25-30(45-33-16-4-8-20-37(33)48-38-21-9-5-17-34(38)45)27-31(26-28)46-35-18-6-10-22-39(35)49-40-23-11-7-19-36(40)46;1-2-12-29(13-3-1)47-33-22-23-43-27-32(33)44-42(47)28-24-30(45-34-14-4-8-18-38(34)48-39-19-9-5-15-35(39)45)26-31(25-28)46-36-16-6-10-20-40(36)49-41-21-11-7-17-37(41)46;1-2-12-29(13-3-1)47-37-27-43-23-22-32(37)44-42(47)28-24-30(45-33-14-4-8-18-38(33)48-39-19-9-5-15-34(39)45)26-31(25-28)46-35-16-6-10-20-40(35)49-41-21-11-7-17-36(41)46/h1-28H;3*1-27H
InChIKeyAYUWLKUULXCTDE-UHFFFAOYSA-N
XLogP45.56
TPSA209.71 Ų
H-Bond Donors
H-Bond Acceptors27
Rotatable Bonds16
Heavy Atoms196
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002533.86
LogP ≤ 545.56
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1027

Analyze 10-[3-phenoxazin-10-yl-5-(1-phenylbenzimidazol-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(3-phenylimidazo[4,5-b]pyridin-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(1-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(3-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]phenoxazine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 10-[3-phenoxazin-10-yl-5-(1-phenylbenzimidazol-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(3-phenylimidazo[4,5-b]pyridin-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(1-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(3-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]phenoxazine?
The IUPAC name of 10-[3-phenoxazin-10-yl-5-(1-phenylbenzimidazol-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(3-phenylimidazo[4,5-b]pyridin-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(1-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(3-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]phenoxazine (CID 157273505) is 10-[3-phenoxazin-10-yl-5-(1-phenylbenzimidazol-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(3-phenylimidazo[4,5-b]pyridin-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(1-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(3-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]phenoxazine.
What is the SMILES notation for 10-[3-phenoxazin-10-yl-5-(1-phenylbenzimidazol-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(3-phenylimidazo[4,5-b]pyridin-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(1-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(3-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]phenoxazine?
The canonical SMILES for 10-[3-phenoxazin-10-yl-5-(1-phenylbenzimidazol-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(3-phenylimidazo[4,5-b]pyridin-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(1-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(3-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]phenoxazine is c1ccc(-n2c(-c3cc(N4c5ccccc5Oc5ccccc54)cc(N4c5ccccc5Oc5ccccc54)c3)nc3ccccc32)cc1.c1ccc(-n2c(-c3cc(N4c5ccccc5Oc5ccccc54)cc(N4c5ccccc5Oc5ccccc54)c3)nc3cccnc32)cc1.c1ccc(-n2c(-c3cc(N4c5ccccc5Oc5ccccc54)cc(N4c5ccccc5Oc5ccccc54)c3)nc3ccncc32)cc1.c1ccc(-n2c(-c3cc(N4c5ccccc5Oc5ccccc54)cc(N4c5ccccc5Oc5ccccc54)c3)nc3cnccc32)cc1.
What is the InChIKey of 10-[3-phenoxazin-10-yl-5-(1-phenylbenzimidazol-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(3-phenylimidazo[4,5-b]pyridin-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(1-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(3-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]phenoxazine?
The InChIKey is AYUWLKUULXCTDE-UHFFFAOYSA-N. The full InChI is InChI=1S/C43H28N4O2.3C42H27N5O2/c1-2-14-30(15-3-1)47-34-17-5-4-16-33(34)44-43(47)29-26-31(45-35-18-6-10-22-39(35)48-40-23-11-7-19-36(40)45)28-32(27-29)46-37-20-8-12-24-41(37)49-42-25-13-9-21-38(42)46;1-2-13-29(14-3-1)47-41(44-32-15-12-24-43-42(32)47)28-25-30(45-33-16-4-8-20-37(33)48-38-21-9-5-17-34(38)45)27-31(26-28)46-35-18-6-10-22-39(35)49-40-23-11-7-19-36(40)46;1-2-12-29(13-3-1)47-33-22-23-43-27-32(33)44-42(47)28-24-30(45-34-14-4-8-18-38(34)48-39-19-9-5-15-35(39)45)26-31(25-28)46-36-16-6-10-20-40(36)49-41-21-11-7-17-37(41)46;1-2-12-29(13-3-1)47-37-27-43-23-22-32(37)44-42(47)28-24-30(45-33-14-4-8-18-38(33)48-39-19-9-5-15-34(39)45)26-31(25-28)46-35-16-6-10-20-40(35)49-41-21-11-7-17-36(41)46/h1-28H;3*1-27H.
What are the key properties of 10-[3-phenoxazin-10-yl-5-(1-phenylbenzimidazol-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(3-phenylimidazo[4,5-b]pyridin-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(1-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(3-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]phenoxazine?
10-[3-phenoxazin-10-yl-5-(1-phenylbenzimidazol-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(3-phenylimidazo[4,5-b]pyridin-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(1-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(3-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]phenoxazine has a molecular weight of 2533.86 g/mol, XLogP of 45.56, 16 rotatable bonds, 0 hydrogen bond donors, and 27 hydrogen bond acceptors.
Where does this data come from?
All data for 10-[3-phenoxazin-10-yl-5-(1-phenylbenzimidazol-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(3-phenylimidazo[4,5-b]pyridin-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(1-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-(3-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]phenoxazine is sourced from PubChem (CID 157273505), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).